Impact of persistent subclinical hypothyroidism on clinical outcomes in non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention.
Chuyi HanKaihang XuLe WangYingyi ZhangRui ZhangAo WeiLijie DongYuecheng HuJinghan XuWenyu LiTingting LiChunwei LiuWei QiDongxia JinJingxia ZhangHongliang CongPublished in: Clinical endocrinology (2021)
Preoperative TSH levels and changes in thyroid hormone levels several months post-PCI in NSTE-ACS patients are highly significant in practice. Persistent SCH is associated with severe coronary artery lesions and MACCE, and may be a predictor for evaluating the prognosis of PCI-treated NSTE-ACS patients.
Keyphrases
- acute coronary syndrome
- percutaneous coronary intervention
- end stage renal disease
- coronary artery
- antiplatelet therapy
- newly diagnosed
- acute myocardial infarction
- coronary artery disease
- ejection fraction
- st segment elevation myocardial infarction
- chronic kidney disease
- healthcare
- primary care
- atrial fibrillation
- peritoneal dialysis
- coronary artery bypass grafting
- prognostic factors
- heart failure
- patient reported
- replacement therapy